Subsequent immunohistochemical analysis of Ki67 (proliferation marker) and N-cadherin (EMT marker) revealed that DGE potentiated DOX’s anti-DLBCL effects, as shown by decreased Ki67- and N-cadherin-positive cells (Fig. 3E, F). Here, MKI67 is linked to diffuse large B-cell lymphoma.